Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation Affibody molecule with a fundamentally reengineered scaffold

Sara Ahlgren, Anna Orlova, Helena Wållberg, Monika Hansson, Mattias Sandström, Richard Lewsley, Anders Wennborg, Lars Abrahmsén, Vladimir Tolmachev, Joachim Feldwisch

Research output: Contribution to journalArticlepeer-review

70 Citations (Scopus)

Fingerprint Dive into the research topics of 'Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation Affibody molecule with a fundamentally reengineered scaffold'. Together they form a unique fingerprint.

Medicine & Life Sciences